Clinical Trials · NCT00005044

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Radiation Therapy Oncology Group
Enrollment
1,579
Start date
Feb 2000
Locations
261 sites, United States, Canada
Primary endpoint
Disease-specific Survival (DSS) (10-year Rates Reported)
View Gonadorelin compound reference